Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings

Total Page:16

File Type:pdf, Size:1020Kb

Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality Acknowledgments This report was prepared by the Center for Behavioral Health Statistics and Quality (CBHSQ), Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Human Services (HHS), and by RTI International (a trade name of Research Triangle Institute), Research Triangle Park, North Carolina. Work by RTI was performed under Contract No. HHSS283201000003C. Public Domain Notice All material appearing in this report is in the public domain and may be reproduced or copied without permission from SAMHSA. However, this publication may not be reproduced or distributed for a fee without the specific, written authorization of the Office of Communications, SAMHSA, U.S. Department of Health and Human Services. When using estimates and quotations from this report, citation of the source is appreciated. Recommended Citation Substance Abuse and Mental Health Services Administration, Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-48, HHS Publication No. (SMA) 14-4863. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2014. Electronic Access and Copies of Publication This publication may be downloaded from http://store.samhsa.gov/home. Hard copies may be obtained from SAMHSA at 1-877-SAMHSA-7 (1-877-726-4727) (English and Español). Originating Office Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality 1 Choke Cherry Road, Room 2-1067 Rockville, MD 20857 September 2014 ii Table of Contents Chapter Page List of Tables .................................................................................................................... vii List of Figures .................................................................................................................... ix Highlights .........................................................................................................................................1 1. Introduction ..........................................................................................................................9 Summary of NSDUH .......................................................................................................... 9 Limitations on Trend Measurement .................................................................................. 10 Format of Report and Data Presentation ........................................................................... 11 Other NSDUH Reports and Data ...................................................................................... 12 2. Illicit Drug Use ..................................................................................................................15 Age .................................................................................................................................... 19 Youths Aged 12 to 17 ....................................................................................................... 21 Young Adults Aged 18 to 25 ............................................................................................ 21 Adults Aged 26 or Older ................................................................................................... 24 Gender ............................................................................................................................... 25 Pregnant Women ............................................................................................................... 26 Race/Ethnicity ................................................................................................................... 26 Education .......................................................................................................................... 26 College Students ............................................................................................................... 27 Employment ...................................................................................................................... 28 Geographic Area ............................................................................................................... 29 Criminal Justice Populations............................................................................................. 29 Frequency of Marijuana Use ............................................................................................. 30 Association with Cigarette and Alcohol Use .................................................................... 31 Driving Under the Influence of Illicit Drugs .................................................................... 31 Source of Prescription Drugs ............................................................................................ 31 3. Alcohol Use .......................................................................................................................35 3.1. Alcohol Use among Persons Aged 12 or Older ....................................................... 35 Age ........................................................................................................................ 36 Gender ................................................................................................................... 37 Pregnant Women ................................................................................................... 37 Race/Ethnicity ....................................................................................................... 38 Education .............................................................................................................. 39 College Students ................................................................................................... 40 Employment .......................................................................................................... 41 Geographic Area ................................................................................................... 41 Association with Illicit Drug and Tobacco Use .................................................... 41 Driving Under the Influence of Alcohol ............................................................... 42 3.2. Underage Alcohol Use ............................................................................................. 44 iii Table of Contents (continued) Chapter Page 4. Tobacco Use.......................................................................................................................47 Age .................................................................................................................................... 48 Gender ............................................................................................................................... 48 Pregnant Women ............................................................................................................... 51 Race/Ethnicity ................................................................................................................... 52 Education .......................................................................................................................... 52 College Students ............................................................................................................... 53 Employment ...................................................................................................................... 53 Geographic Area ............................................................................................................... 53 Association with Illicit Drug and Alcohol Use ................................................................. 54 Frequency of Cigarette Use .............................................................................................. 54 5. Initiation of Substance Use ................................................................................................57 Initiation of Illicit Drug Use ............................................................................................. 58 Comparison, by Drug ........................................................................................................ 59 Marijuana .......................................................................................................................... 61 Cocaine ............................................................................................................................. 62 Heroin ............................................................................................................................... 62 Hallucinogens ................................................................................................................... 63 Inhalants ............................................................................................................................ 64 Psychotherapeutics ............................................................................................................ 64 Alcohol .............................................................................................................................. 67 Tobacco ............................................................................................................................
Recommended publications
  • Experiences of Disengagement from Mental Health Services: an Interpretative Study
    EXPERIENCES OF DISENGAGEMENT FROM MENTAL HEALTH SERVICES: AN INTERPRETATIVE STUDY by CHRISTOPHER WAGSTAFF A thesis submitted to the University of Birmingham for the degree of DOCTOR OF PHILOSOPHY Nursing, Health & Population Sciences College of Medical & Dental Sciences University of Birmingham 2015 University of Birmingham Research Archive e-theses repository This unpublished thesis/dissertation is copyright of the author and/or third parties. The intellectual property rights of the author or third parties in respect of this work are as defined by The Copyright Designs and Patents Act 1988 or as modified by any successor legislation. Any use made of information contained in this thesis/dissertation must be in accordance with that legislation and must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the permission of the copyright holder. ABSTRACT Whilst there is evidence of a range of effective treatments available for people with severe mental health problems (SMHP), people frequently disengage from mental health services (MHS). This thesis investigates experiences of disengagement of people with SMHP and comprises two studies: 1) semi-structured interviews to elicit the experiences of people with SMHP and a history of disengagement from MHS; and 2) building on those findings, focus groups with staff from assertive outreach teams (specialising in providing care for people with SMHP and a history of disengagement). The participants were those perceived as the most disengaged from MHS yet they were willing to engage with the research. Interpretative phenomenological analysis was used to develop themes for individual participants and then across the participants. Disengagement from MHS was part of a wider experience of a limited connection to social structures, including an ambivalent and complex relationship with MHS.
    [Show full text]
  • Drug Facts Cigarettes and Other Tobacco Products
    Cigarettes and Other Tobacco Products Tobacco use is the leading preventable cause smokes about 1 pack (25 cigarettes) daily of disease, disability, and death in the United gets 250 “hits” of nicotine each day. States. According to the Centers for Disease Control and Prevention (CDC), cigarette Upon entering the bloodstream, nicotine smoking results in more than 480,000 immediately stimulates the adrenal glands premature deaths in the United States each to release the hormone epinephrine year—about 1 in every 5 U.S. deaths—and an (adrenaline). Epinephrine stimulates the additional 16 million people suffer with a central nervous system and increases blood serious illness caused by smoking. In fact, for pressure, respiration, and heart rate. every one person who dies from smoking, about 30 more suffer from at least one Similar to other addictive drugs like cocaine serious tobacco-related illness.1 and heroin, nicotine increases levels of the neurotransmitter dopamine, which affects The harmful effects of smoking extend far the brain pathways that control reward and beyond the smoker. Exposure to secondhand pleasure. For many tobacco users, long- smoke can cause serious diseases and death. term brain changes induced by continued Each year, an estimated 88 million nicotine exposure result in addiction—a nonsmoking Americans are regularly exposed condition of compulsive drug seeking and to secondhand smoke and almost 41,000 use, even in the face of negative nonsmokers die from diseases caused by consequences. Studies suggest that secondhand smoke exposure.1,2 additional compounds in tobacco smoke, such as acetaldehyde, may enhance How Does Tobacco Affect the Brain? nicotine’s effects on the brain.3 Cigarettes and other forms of tobacco— When an addicted user tries to quit, he or including cigars, pipe tobacco, snuff, and she experiences withdrawal symptoms chewing tobacco—contain the addictive including irritability, attention difficulties, drug nicotine.
    [Show full text]
  • Hallucinogens - LSD, Peyote, Psilocybin, and PCP
    Hallucinogens - LSD, Peyote, Psilocybin, and PCP Hallucinogenic compounds found in some • Psilocybin (4-phosphoryloxy-N,N- plants and mushrooms (or their extracts) dimethyltryptamine) is obtained from have been used—mostly during religious certain types of mushrooms that are rituals—for centuries. Almost all indigenous to tropical and subtropical hallucinogens contain nitrogen and are regions of South America, Mexico, and classified as alkaloids. Many hallucinogens the United States. These mushrooms have chemical structures similar to those of typically contain less than 0.5 percent natural neurotransmitters (e.g., psilocybin plus trace amounts of acetylcholine-, serotonin-, or catecholamine- psilocin, another hallucinogenic like). While the exact mechanisms by which substance. hallucinogens exert their effects remain • PCP (phencyclidine) was developed in unclear, research suggests that these drugs the 1950s as an intravenous anesthetic. work, at least partially, by temporarily Its use has since been discontinued due interfering with neurotransmitter action or to serious adverse effects. by binding to their receptor sites. This DrugFacts will discuss four common types of How Are Hallucinogens Abused? hallucinogens: The very same characteristics that led to • LSD (d-lysergic acid diethylamide) is the incorporation of hallucinogens into one of the most potent mood-changing ritualistic or spiritual traditions have also chemicals. It was discovered in 1938 led to their propagation as drugs of abuse. and is manufactured from lysergic acid, Importantly, and unlike most other drugs, which is found in ergot, a fungus that the effects of hallucinogens are highly grows on rye and other grains. variable and unreliable, producing different • Peyote is a small, spineless cactus in effects in different people at different times.
    [Show full text]
  • Hallucinogens - LSD, Peyote, Psilocybin, and PCP
    Information for Behavioral Health Providers in Primary Care Hallucinogens - LSD, Peyote, Psilocybin, and PCP What are Hallucinogens? Hallucinogenic compounds found in some plants and mushrooms (or their extracts) have been used— mostly during religious rituals—for centuries. Almost all hallucinogens contain nitrogen and are classified as alkaloids. Many hallucinogens have chemical structures similar to those of natural neurotransmitters (e.g., acetylcholine-, serotonin-, or catecholamine-like). While the exact mechanisms by which hallucinogens exert their effects remain unclear, research suggests that these drugs work, at least partially, by temporarily interfering with neurotransmitter action or by binding to their receptor sites. This InfoFacts will discuss four common types of hallucinogens: LSD (d-lysergic acid diethylamide) is one of the most potent mood-changing chemicals. It was discovered in 1938 and is manufactured from lysergic acid, which is found in ergot, a fungus that grows on rye and other grains. Peyote is a small, spineless cactus in which the principal active ingredient is mescaline. This plant has been used by natives in northern Mexico and the southwestern United States as a part of religious ceremonies. Mescaline can also be produced through chemical synthesis. Psilocybin (4-phosphoryloxy-N, N-dimethyltryptamine) is obtained from certain types of mushrooms that are indigenous to tropical and subtropical regions of South America, Mexico, and the United States. These mushrooms typically contain less than 0.5 percent psilocybin plus trace amounts of psilocin, another hallucinogenic substance. PCP (phencyclidine) was developed in the 1950s as an intravenous anesthetic. Its use has since been discontinued due to serious adverse effects. How Are Hallucinogens Abused? The very same characteristics that led to the incorporation of hallucinogens into ritualistic or spiritual traditions have also led to their propagation as drugs of abuse.
    [Show full text]
  • Substance Abuse and Dependence
    9 Substance Abuse and Dependence CHAPTER CHAPTER OUTLINE CLASSIFICATION OF SUBSTANCE-RELATED THEORETICAL PERSPECTIVES 310–316 Residential Approaches DISORDERS 291–296 Biological Perspectives Psychodynamic Approaches Substance Abuse and Dependence Learning Perspectives Behavioral Approaches Addiction and Other Forms of Compulsive Cognitive Perspectives Relapse-Prevention Training Behavior Psychodynamic Perspectives SUMMING UP 325–326 Racial and Ethnic Differences in Substance Sociocultural Perspectives Use Disorders TREATMENT OF SUBSTANCE ABUSE Pathways to Drug Dependence AND DEPENDENCE 316–325 DRUGS OF ABUSE 296–310 Biological Approaches Depressants Culturally Sensitive Treatment Stimulants of Alcoholism Hallucinogens Nonprofessional Support Groups TRUTH or FICTION T❑ F❑ Heroin accounts for more deaths “Nothing and Nobody Comes Before than any other drug. (p. 291) T❑ F❑ You cannot be psychologically My Coke” dependent on a drug without also being She had just caught me with cocaine again after I had managed to convince her that physically dependent on it. (p. 295) I hadn’t used in over a month. Of course I had been tooting (snorting) almost every T❑ F❑ More teenagers and young adults die day, but I had managed to cover my tracks a little better than usual. So she said to from alcohol-related motor vehicle accidents me that I was going to have to make a choice—either cocaine or her. Before she than from any other cause. (p. 297) finished the sentence, I knew what was coming, so I told her to think carefully about what she was going to say. It was clear to me that there wasn’t a choice. I love my T❑ F❑ It is safe to let someone who has wife, but I’m not going to choose anything over cocaine.
    [Show full text]
  • Drug and Alcohol Abuse Prevention Handbook FOREWARD
    Drug and Alcohol Abuse Prevention Handbook FOREWARD Grayson College recognizes that the illicit use of drugs and/or the abuse of alcohol are a persistent health problem of major proportion affecting our society physically, mentally, and socially. Illicit drug use and /or alcohol abuse can adversely affect an individual’s personal life, safety, health, and mental and physical performance. It is the intent of GC to provide employees and students pertinent information related to illicit drug use and/or alcohol abuse in an effort to prevent such harm. GC is committed to promoting and maintaining a work and academic environment that is free from illegal alcohol and drug use and abuse, in accordance with all federal, state, and local laws. Students, employees, and visitors are prohibited from possessing, consuming, manufacturing, dispensing, or being under the influence of alcohol/illegal drugs or engaging in improper self- medication while on college property or college business. Any member of the college community who violates this policy is subject to both prosecution and punishment under federal, state, and local laws to disciplinary proceedings by the college. This alcohol/drug policy is not designed to punish people for seeking rehabilitation. All information about those individuals who voluntarily avail themselves of drug or alcohol counseling or rehabilitation will not be used as a basis for disciplinary action or be used against an individual in any way. College employees and students who violate the alcohol/drug policy shall be informed about and referred to services to assist them in determining whether they are abusing drugs and alcohol or are chemically dependent.
    [Show full text]
  • Medications to Treat Opioid Use Disorder Research Report
    Research Report Revised Junio 2018 Medications to Treat Opioid Use Disorder Research Report Table of Contents Medications to Treat Opioid Use Disorder Research Report Overview How do medications to treat opioid use disorder work? How effective are medications to treat opioid use disorder? What are misconceptions about maintenance treatment? What is the treatment need versus the diversion risk for opioid use disorder treatment? What is the impact of medication for opioid use disorder treatment on HIV/HCV outcomes? How is opioid use disorder treated in the criminal justice system? Is medication to treat opioid use disorder available in the military? What treatment is available for pregnant mothers and their babies? How much does opioid treatment cost? Is naloxone accessible? References Page 1 Medications to Treat Opioid Use Disorder Research Report Discusses effective medications used to treat opioid use disorders: methadone, buprenorphine, and naltrexone. Overview An estimated 1.4 million people in the United States had a substance use disorder related to prescription opioids in 2019.1 However, only a fraction of people with prescription opioid use disorders receive tailored treatment (22 percent in 2019).1 Overdose deaths involving prescription opioids more than quadrupled from 1999 through 2016 followed by significant declines reported in both 2018 and 2019.2,3 Besides overdose, consequences of the opioid crisis include a rising incidence of infants born dependent on opioids because their mothers used these substances during pregnancy4,5 and increased spread of infectious diseases, including HIV and hepatitis C (HCV), as was seen in 2015 in southern Indiana.6 Effective prevention and treatment strategies exist for opioid misuse and use disorder but are highly underutilized across the United States.
    [Show full text]
  • Methylphenidate Amplifies the Potency and Reinforcing Effects Of
    ARTICLE Received 1 Aug 2013 | Accepted 7 Oct 2013 | Published 5 Nov 2013 DOI: 10.1038/ncomms3720 Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression Erin S. Calipari1, Mark J. Ferris1, Ali Salahpour2, Marc G. Caron3 & Sara R. Jones1 Methylphenidate (MPH) is commonly diverted for recreational use, but the neurobiological consequences of exposure to MPH at high, abused doses are not well defined. Here we show that MPH self-administration in rats increases dopamine transporter (DAT) levels and enhances the potency of MPH and amphetamine on dopamine responses and drug-seeking behaviours, without altering cocaine effects. Genetic overexpression of the DAT in mice mimics these effects, confirming that MPH self-administration-induced increases in DAT levels are sufficient to induce the changes. Further, this work outlines a basic mechanism by which increases in DAT levels, regardless of how they occur, are capable of increasing the rewarding and reinforcing effects of select psychostimulant drugs, and suggests that indivi- duals with elevated DAT levels, such as ADHD sufferers, may be more susceptible to the addictive effects of amphetamine-like drugs. 1 Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA. 2 Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada M5S1A8. 3 Department of Cell Biology, Medicine and Neurobiology, Duke University Medical Center, Durham, North Carolina 27710, USA. Correspondence and requests for materials should be addressed to S.R.J. (email: [email protected]). NATURE COMMUNICATIONS | 4:2720 | DOI: 10.1038/ncomms3720 | www.nature.com/naturecommunications 1 & 2013 Macmillan Publishers Limited.
    [Show full text]
  • Fuel Properties Comparison
    Alternative Fuels Data Center Fuel Properties Comparison Compressed Liquefied Low Sulfur Gasoline/E10 Biodiesel Propane (LPG) Natural Gas Natural Gas Ethanol/E100 Methanol Hydrogen Electricity Diesel (CNG) (LNG) Chemical C4 to C12 and C8 to C25 Methyl esters of C3H8 (majority) CH4 (majority), CH4 same as CNG CH3CH2OH CH3OH H2 N/A Structure [1] Ethanol ≤ to C12 to C22 fatty acids and C4H10 C2H6 and inert with inert gasses 10% (minority) gases <0.5% (a) Fuel Material Crude Oil Crude Oil Fats and oils from A by-product of Underground Underground Corn, grains, or Natural gas, coal, Natural gas, Natural gas, coal, (feedstocks) sources such as petroleum reserves and reserves and agricultural waste or woody biomass methanol, and nuclear, wind, soybeans, waste refining or renewable renewable (cellulose) electrolysis of hydro, solar, and cooking oil, animal natural gas biogas biogas water small percentages fats, and rapeseed processing of geothermal and biomass Gasoline or 1 gal = 1.00 1 gal = 1.12 B100 1 gal = 0.74 GGE 1 lb. = 0.18 GGE 1 lb. = 0.19 GGE 1 gal = 0.67 GGE 1 gal = 0.50 GGE 1 lb. = 0.45 1 kWh = 0.030 Diesel Gallon GGE GGE 1 gal = 1.05 GGE 1 gal = 0.66 DGE 1 lb. = 0.16 DGE 1 lb. = 0.17 DGE 1 gal = 0.59 DGE 1 gal = 0.45 DGE GGE GGE Equivalent 1 gal = 0.88 1 gal = 1.00 1 gal = 0.93 DGE 1 lb. = 0.40 1 kWh = 0.027 (GGE or DGE) DGE DGE B20 DGE DGE 1 gal = 1.11 GGE 1 kg = 1 GGE 1 gal = 0.99 DGE 1 kg = 0.9 DGE Energy 1 gallon of 1 gallon of 1 gallon of B100 1 gallon of 5.66 lb., or 5.37 lb.
    [Show full text]
  • National Vital Statistics Report: Drugs Most Frequently Involved In
    National Vital Statistics Reports Volume 67, Number 9 December 12, 2018 Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2011–2016 by Holly Hedegaard, M.D., M.S.P.H., and Brigham A. Bastian, B.S., National Center for Health Statistics; James P. Trinidad, M.P.H., M.S., U.S. Food and Drug Administration; Merianne Spencer, M.P.H., and Margaret Warner, Ph.D., National Center for Health Statistics Abstract overdose deaths involving methadone decreased from 1.4 per 100,000 in 2011 to 1.1 in 2016. The 10 most frequently Objective—This report identifies the specific drugs involved mentioned drugs often were found in combination with each most frequently in drug overdose deaths in the United States other. The drugs most frequently mentioned varied by the intent from 2011 through 2016. of the drug overdose death. In 2016, the drugs most frequently Methods—Record-level data from the 2011–2016 National mentioned in unintentional drug overdose deaths were fentanyl, Vital Statistics System–Mortality files were linked to electronic heroin, and cocaine, while the drugs most frequently mentioned files containing literal text information from death certificates. in suicides by drug overdose were oxycodone, diphenhydramine, Drug overdose deaths were identified using the International hydrocodone, and alprazolam. Classification of Diseases, Tenth Revision underlying cause- Conclusions—This report identifies patterns in the specific of-death codes X40–X44, X60–X64, X85, and Y10–Y14. Drug drugs most frequently involved in drug overdose deaths from mentions were identified by searching the literal text in three 2011 through 2016 and highlights the importance of complete fields of the death certificate: the causes of death from Part I, and accurate reporting in the literal text on death certificates.
    [Show full text]
  • Bacterial Contamination of Packaged Smokeless Tobacco Sold in India
    Research Paper Tobacco Prevention & Cessation Bacterial contamination of packaged smokeless tobacco sold in India Rashmi Mehra1, Vikrant Mohanty1, Aswini Y. Balappanavar1, Shivam Kapoor1 ABSTRACT INTRODUCTION About 21.4% of India’s population uses smokeless tobacco products (SLT), yet limited data are available on their microbial contamination. To AFFILIATION understand the potential microbiological risks associated with SLT use, the 1 Department of Public Health present study aims to investigate bacterial contamination of tobacco and the Dentistry, Maulana Azad Institute of Dental Sciences, New Delhi, types of microbes that could be cultured from SLT products. India METHODS Twenty-two brands of SLT products, including paan masala, khaini, gutka and tobacco-containing dentifrices were examined and cultured by using CORRESPONDENCE TO Rashmi Mehra. Department of appropriate selective and differential media including MacConkey agar and CLED Public Health Dentistry, Maulana agar. This was followed by a sequence of further identification by biochemical Azad Institute of Dental Sciences, New Delhi, India. tests. E-mail: [email protected] RESULTS All 22 types of SLT products showed growth of aerobic bacteria. The most KEYWORDS common bacteria isolated were Pseudomonas aeruginosa followed by Streptococcus contamination, bacteria, faecalis. Other bacteria that were isolated from products, in traces, included toxicology, smokeless tobacco, Klebsiella spp., E. coli, and Bacillus subtilus. tobacco constituents CONCLUSIONS This study raises and
    [Show full text]
  • Tobacco Use: a Smart Guide
    1 Tobacco Use: A Smart Guide “STOPPING TAKES HARD WORK AND A LOT OF EFFORT, BUT – YOU CAN STOP TOBACCO” THE PROCESS OF QUITTING Do you find quitting tobacco difficult? The reason you continue to use tobacco is not because you are weak-willed or irresponsible, but because you are addicted. Nicotine is said to be more addictive than brown sugar (heroin) or cocaine. That is why people find it so difficult to stop, once they are habituated. The quitting process involves three steps: A. Preparation before quitting B. Actual quitting and C. Life after quitting. This manual will guide you through each of these steps. YOU NEED TO KNOW Before trying to quit tobacco you need to know a few facts about tobacco: • Tobacco comes in different forms….and all contain nicotine, the addictive substance. • Smoking forms of tobacco are beedis, cigarettes, cigars, chuttas, dhumti, pipe, hooklis, and hookah. • Smokeless forms of tobacco include chewing paan (betel quid) with zarda (tobacco), guthka, pan masala, manipuri tobacco, mawa, khaini, kaddi pudi, chewing tobacco leaves, mishri, gul, snuff, tobacco tooth paste and as tobacco water. Tobacco Facts • Tobacco is the leading cause of preventable death. • Each year tobacco kills 40,00,000 people. 2500 Indians die EVERYDAY due to tobacco related diseases. Deaths from tobacco use world wide are more than that from cocaine, heroin, alcohol, fires, accidents, murder, suicide, and AIDS COMBINED. • If you use tobacco, you are likely to die 15 years earlier. Tobacco Use: A Smart Guide 2 • Tobacco affects all the organs in the body from head to toe.
    [Show full text]